Arsenalbio

Developer of immune cell therapies for cancer treatment

placeSan Francisco, California, United States calendar_todayFounded 2019 groups178 employees language arsenalbio.com

Registered entities

Social engagement

Social engagement: 29.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include Bristol-Myers Squibb, Westlake Village Biopartners, SoftBank Vision Fund, PICI.

Investor typeCountShare
Venture capital1250%
Private equity28%
Angel & family office14%
Bank & private debt14%
Other / undisclosed833%

Recent activity

3 Mar 2026
Event
PMWC - Precision Medicine World Conference 2026
20 Jan 2026
Event
Evolution Summit panel discussion on CAR-T cell therapy and personalized cancer treatment
8 Dec 2025
Event
ArsenalBio's Farah Anwar webinar on balancing scientific rigor, operational efficiency, and the patient experience
Coming soon